ArticleThe Korean journal of helicobacter and upper gastrointestinal research2025

Evaluation of the Safety and Efficacy of K-CAB (Tegoprazan) as Symptomatic Maintenance Therapy in Patients With NERD: A Multicenter, Randomized Double-Blinded Controlled Trial.

Yong Hwan Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.